Menopause and nutraceuticals
DOI:
https://doi.org/10.7175/cmi.v9i3.1193References
Veling M. Regulatory information resources for nutraceuticals and functional foods: resource guide. © 2012 National Research Council of Canada. Available at http://nparc.cisti-icist.nrc-cnrc.gc.ca/npsi/ctrl?action=rtdoc&an=19588985&article=0&lang=en&fd=main&ext=. (last accessed July 2015)
Ufficio stampa IMS Health Italia. IMS Health Italia: Nutraceutica - Italia uno dei mercati europei più maturi. Bologna, 17 aprile 2014. Available at http://www.imshealth.com/ (last accessed July 2015)
IMS Health Italia. Nutraceutica forum, 2015. Milano, 16 giugno 2015
Franconi F, Montilla S, Vella S. Farmacologia di genere. Torino: SEEd Medical Publishers, 2010
Ufficio stampa IMS Health Italia. IMS Health Italia: FARMACIA - nei primi due mesi del 2015 il mercato commerciale è cresciuto del 3,7%. Bologna, 17 aprile 2015. Available at http://www.imshealth.com/ (last accessed July 2015)
AbouZahr C. Progress and challenges in women’s health: an analysis of levels and patterns of mortality and morbidity. Contraception 2014; 90: S3-S13; http://dx.doi.org/10.1016/j.contraception.2014.03.007
Borrelli F, Ernst E. Alternative and complementary therapies for the menopause. Maturitas 2010; 66: 333-43; http://dx.doi.org/10.1016/j.maturitas.2010.05.010
Hulley S, Grady D, Bush T, et al.; for the Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998; 280: 605-13; http://dx.doi.org/10.1001/jama.280.7.605
Writing Group for the Women’s Health Initiative Investigators; Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33; http://dx.doi.org/10.1001/jama.288.3.321
GoPubMed. Available at http://www.gopubmed.org/web/gopubmed/ (last accessed July 2015)
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial 4.0 Licence that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)